Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Exenatide Once a Week Just as Effective as Twice Daily for Glycemic Control
Link ID 8569
Title Exenatide Once a Week Just as Effective as Twice Daily for Glycemic Control
Url http://www.medscape.com/viewarticle/580314?src=rss
Description Patients with type 2 diabetes taking a weekly regimen of the antidiabetes drug exenatide experienced greater changes in hemoglobin A1c levels and were more likely to reach target glucose levels. Medscape Medical News
Category Articles > Cardiology
Keywords
Date Sep 11, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Alendronate Use and Risk of Atrial Fibrillation
  Due to concern about a possible link between bisphosphonates and cardiac arrhythmias, an observational study looked at whether alendronate use is related to incident atrial fibrillation risk in women. The North American Menopause Society (NAMS)
Category:   Articles > Cardiology


2. FDA Safety Changes: Tekturna, Diovan, EstroGel
  The FDA has approved revisions to the safety labeling for aliskiren hemifumarate tablets (Tekturna), valsartan tablets (Diovan), and estradiol 0.06% gel (EstroGel). Medscape Medical News
Category:   Articles > Cardiology


3. New MESA Data Show Obesity Is Not Inevitable
  A new look at the Multi-Ethnic Study of Atherosclerosis has found that 30% to 50% of blacks, whites, and Hispanics, but only 5% of Chinese Americans, are obese, showing that obesity is not inevitable. Medscape Medical News
Category:   Articles > Cardiology


4. "Precipitating Factors" Influence Heart Failure Outcomes
  More attention to factors that contribute to hospitalizations for heart failure, such as pneumonia or uncontrolled hypertension, could improve overall management of this condition, a new study shows. Medscape Medical News
Category:   Articles > Cardiology


5. Novel Thrombolytic Microplasmin Safe in Acute Ischemic Stroke
  Results of a phase 2 trial showed safety with microplasmin in patients with acute ischemic stroke treated between 4 and 12 hours, with no increase in bleeding vs placebo. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS